Travere Therapeutics, Inc. · NASDAQ:TVTX
Janus Henderson Group PLC reported a 8.50% stake in Travere Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 8.50% stake in Travere Therapeutics, Inc., 7,566,963 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).
- Stake
- 8.50%
- Shares
- 7,566,963
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.50% | 7,566,963 |
Source
Related
- Travere Therapeutics, Inc.
- Janus Henderson Group PLC
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 7, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026